icon 11630 SW 97 Street, Miami, Florida 33176, US

Tag: IMT504

CURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINE

Press Release

License from Mid-Atlantic BioTherapeutics for IMT504 Broadens Scope of Initial License Beyond Treatment of Symptomatic Rabies Boca Raton, FL, October 7, 2021 – Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”) announced today that the Company has reached […]

Read More>>

Cookies & Privacy

By using this website, you agree to us using cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
More Information